"insulin aspart" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "insulin",
        "3": "aspartate",
        "alt2": "aspart(ate)"
      },
      "expansion": "insulin + aspart(ate)",
      "name": "af"
    }
  ],
  "etymology_text": "From insulin + aspart(ate).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "insulin aspart (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Healthcare",
            "Fundamental",
            "Health",
            "Body"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A short-acting modified recombinant form of insulin (a short-acting insulin analogue) administered by subcutaneous injection in the treatment of type 1 and type 2 diabetes. Trade names (trademarks) include NovoLog, Fiasp, and others."
      ],
      "id": "en-insulin_aspart-en-noun-PnPtLXUy",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "short-acting",
          "short-acting"
        ],
        [
          "recombinant",
          "recombinant"
        ],
        [
          "insulin",
          "insulin"
        ],
        [
          "insulin analogue",
          "insulin analogue"
        ],
        [
          "subcutaneous",
          "subcutaneous"
        ],
        [
          "injection",
          "injection"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A short-acting modified recombinant form of insulin (a short-acting insulin analogue) administered by subcutaneous injection in the treatment of type 1 and type 2 diabetes. Trade names (trademarks) include NovoLog, Fiasp, and others."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌɪn.səl.ɪn ˈæ.spɑɹt/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "insulin aspart"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "insulin",
        "3": "aspartate",
        "alt2": "aspart(ate)"
      },
      "expansion": "insulin + aspart(ate)",
      "name": "af"
    }
  ],
  "etymology_text": "From insulin + aspart(ate).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "insulin aspart (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English compound terms",
        "English entries with incorrect language header",
        "English lemmas",
        "English multiword terms",
        "English nouns",
        "English uncountable nouns",
        "Pages with 1 entry",
        "Pages with entries",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A short-acting modified recombinant form of insulin (a short-acting insulin analogue) administered by subcutaneous injection in the treatment of type 1 and type 2 diabetes. Trade names (trademarks) include NovoLog, Fiasp, and others."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "short-acting",
          "short-acting"
        ],
        [
          "recombinant",
          "recombinant"
        ],
        [
          "insulin",
          "insulin"
        ],
        [
          "insulin analogue",
          "insulin analogue"
        ],
        [
          "subcutaneous",
          "subcutaneous"
        ],
        [
          "injection",
          "injection"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A short-acting modified recombinant form of insulin (a short-acting insulin analogue) administered by subcutaneous injection in the treatment of type 1 and type 2 diabetes. Trade names (trademarks) include NovoLog, Fiasp, and others."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌɪn.səl.ɪn ˈæ.spɑɹt/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "insulin aspart"
}